Press Release Source: Alliance for Stem Cell Research

Advocacy Group Applauds Stem Cell Institute
Wednesday August 3, 4:04 pm ET
New Generation of Scientists: First Stem Cell Training Grants to Be Approved

SANTA MONICA, Calif., Aug. 3 /PRNewswire/ -- Susan DeLaurentis, CEO of the Alliance for Stem Cell Research, responded today to the announcement by the California Institute for Regenerative Medicine (CIRM) of its recommendations for a first set of training grants, stating, "Despite all of the obstacles the opponents of research have thrown at us, we are pleased that the first wave of stem cell research grants is underway."

DeLaurentis added that, "The launch of the training grant program will strengthen the talent pool of stem cell researchers and bolster the CIRM's ability to support research. This will move California closer to curing diseases and saving lives. I applaud the CIRM for its determination to move forward with its scientific agenda, despite numerous legal and political distractions interfering with the voter mandate to fund this vital research."

The CIRM plans to award $45 million over three years in training grants to public colleges and nonprofit academic research institutions in California to fund stem cell research training for pre-doctoral students, post-doctoral students and fellows. This will provide vitally needed funding to ensure that there is a corps of trained researchers to enter the field of stem cell research.

Litigation funded by opponents of Prop. 71 has delayed the CIRM's ability to sell bonds to fund stem cell research. While plans are underway to secure interim funding for training grants and projects, the Alliance has called on the plaintiffs to drop their lawsuit so the will of California voters can be carried out and the research can move forward.

About the Alliance for Stem Cell Research

The mission of the Alliance for Stem Cell Research (ASCR) is to advance the field of stem cell research and regenerative medicine and to educate the public about its potential and progress.

About Susan DeLaurentis

Susan DeLaurentis is president and CEO of the Alliance for Stem Cell Research. Her start in patient advocacy came in 1988, when her friend Elizabeth Glaser was diagnosed, along with her children, with AIDS. In response, Susan, Elizabeth, and their friend Susan Zeegen founded the Pediatric AIDS Foundation to help reduce the impact and incidence of HIV/AIDS in children. Today, the Elizabeth Glaser Pediatric AIDS Foundation is a world- renowned patient advocacy group and the leading national non-profit dedicated to identifying, preventing and conducting critical pediatric AIDS research.

Source: Alliance for Stem Cell Research